About
Profile
Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, govern
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
PRTK
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Paratek Pharmaceuticals GAAP EPS of -$0.35 beats by $0.03, revenue of $31.24M misses by $0.39M
- Paratek Pharmaceuticals Q1 2023 Earnings Preview
- Paratek a new buy at Jefferies on growing antibiotics business
- Paratek Pharmaceuticals shares purchased by Highland Capital Management
- Paratek Pharmaceuticals up 20% on takeout speculation - report
- Paratek Pharmaceuticals GAAP EPS of -$0.13 misses by $0.23, revenue of $75.6M beats by $12.13M
- Paratek stock slumps ~25% despite Q4 revenue beat as FY23 sales outlook below estimates
- Paratek Pharmaceuticals FY 2022 Earnings Preview
- Paratek/ Zai Lab antibiotic added for reimbursement in China
- Paratek's treatment for pulmonary anthrax shows promise in study
- Paratek Pharmaceuticals GAAP EPS of -$0.38, revenue of $30.2M
- Paratek Pharmaceuticals Q3 2022 Earnings Preview
- Paratek Pharmaceuticals GAAP EPS of -$0.33 beats by $0.01, revenue of $29.6M beats by $0.42M
- Paratek Pharmaceuticals Q2 2022 Earnings Preview
- Paratek Pharmaceuticals stock soars postmarket on fast track designation for Nuzyra
- Paratek Pharmaceuticals GAAP EPS of -$0.35 in-line, revenue of $24.86M misses by $2.29M
- Paratek Pharmaceuticals Q1 2022 Earnings Preview
- Paratek Pharmaceuticals GAAP EPS of -$1.22 misses by $0.31, revenue of $130.16M misses by $3.57M
- Paratek, Zai Labs up on Chinese approval of Nuzyra for pneumonia, skin infections
- Paratek Pharmaceuticals rises 6% after Q3 2021 earnings beat
PEERS
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| November 8, 2021 | -0.37 / -0.4501 | 24.4M / 23.82M |
Beat! |
| August 9, 2021 | 0.2 / 0.3575 | 57.49M / 58.01M | |
| May 17, 2021 | -0.39 / -0.5633 | 16.43M / 16.53M | |
| May 5, 2021 | - / -0.34 | - / 18.1M | |
| February 24, 2021 | -0.54 / -0.475 | 16.02M / 16.2M | |
| November 5, 2020 | -0.46 / -0.61 | 13.66M / 11.89M |
Beat! |
| August 10, 2020 | -0.53 / -0.07 | 9.33M / 38.04M | |
| May 11, 2020 | -0.66 / -0.8 | 7.3M / 7.46M | |
| February 25, 2020 | -0.81 / -1.04 | 8.97M / 5.43M |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2023 | 2.23 | 2.19 |
2.24
|
2.19
|
4.8M | 1.83% | |||
| Sep 19, 2023 | 2.19 | 2.19 |
2.2
|
2.18
|
5.1M | 0% | |||
| Sep 18, 2023 | 2.19 | 2.19 |
2.21
|
2.18
|
3.3M | 0.46% | |||
| Sep 15, 2023 | 2.18 | 2.2 |
2.2
|
2.18
|
700K | -0.46% | |||
| Sep 14, 2023 | 2.19 | 2.21 |
2.21
|
2.19
|
230K | -0.45% | |||
| Sep 13, 2023 | 2.2 | 2.21 |
2.22
|
2.2
|
1.4M | -0.45% | |||
| Sep 12, 2023 | 2.21 | 2.21 |
2.22
|
2.21
|
249K | 0% | |||
| Sep 11, 2023 | 2.21 | 2.22 |
2.22
|
2.21
|
346K | -0.45% | |||
| Sep 8, 2023 | 2.22 | 2.21 |
2.22
|
2.21
|
121K | 0% | |||
| Sep 7, 2023 | 2.22 | 2.2 |
2.22
|
2.2
|
392K | 0.91% | |||
| Sep 6, 2023 | 2.2 | 2.22 |
2.22
|
2.2
|
150K | -0.9% | |||
| Sep 5, 2023 | 2.22 | 2.2 |
2.22
|
2.19
|
592K | 1.37% | |||
| Sep 1, 2023 | 2.19 | 2.21 |
2.23
|
2.19
|
250K | -0.9% | |||
| Aug 31, 2023 | 2.21 | 2.2 |
2.22
|
2.19
|
535K | 0.45% | |||
| Aug 30, 2023 | 2.2 | 2.19 |
2.22
|
2.19
|
260K | -0.45% | |||
| Aug 29, 2023 | 2.21 | 2.19 |
2.21
|
2.19
|
322K | 0.91% | |||
| Aug 28, 2023 | 2.19 | 2.19 |
2.21
|
2.18
|
231K | -0.45% | |||
| Aug 25, 2023 | 2.2 | 2.2 |
2.21
|
2.19
|
232K | 0% | |||
| Aug 24, 2023 | 2.2 | 2.19 |
2.21
|
2.18
|
453K | 0.92% | |||
| Aug 23, 2023 | 2.18 | 2.18 |
2.19
|
2.18
|
93.8K | 0% | |||
| Aug 22, 2023 | 2.18 | 2.18 |
2.19
|
2.18
|
412K | 0.46% | |||
| Aug 21, 2023 | 2.17 | 2.2 |
2.21
|
2.17
|
310K | -1.81% | |||
| Aug 18, 2023 | 2.21 | 2.18 |
2.21
|
2.18
|
436K | 0.91% | |||
| Aug 17, 2023 | 2.19 | 2.19 |
2.21
|
2.18
|
543K | 0.46% | |||
| Aug 16, 2023 | 2.18 | 2.18 |
2.19
|
2.18
|
129K | -0.46% | |||
| Aug 15, 2023 | 2.19 | 2.18 |
2.19
|
2.18
|
187K | 0.46% | |||
| Aug 14, 2023 | 2.18 | 2.18 |
2.19
|
2.18
|
230K | 0% | |||
| Aug 11, 2023 | 2.18 | 2.19 |
2.19
|
2.18
|
628K | -0.91% | |||
| Aug 10, 2023 | 2.2 | 2.19 |
2.2
|
2.19
|
103K | 0.46% | |||
| Aug 9, 2023 | 2.19 | 2.2 |
2.22
|
2.19
|
397K | 0% | |||
| Aug 8, 2023 | 2.19 | 2.19 |
2.2
|
2.19
|
170K | -0.45% | |||
| Aug 7, 2023 | 2.2 | 2.21 |
2.22
|
2.2
|
272K | -0.9% | |||
| Aug 4, 2023 | 2.22 | 2.21 |
2.23
|
2.2
|
442K | 0.91% | |||
| Aug 3, 2023 | 2.2 | 2.2 |
2.23
|
2.2
|
709K | -0.9% | |||
| Aug 2, 2023 | 2.22 | 2.19 |
2.23
|
2.19
|
369K | 0.45% | |||
| Aug 1, 2023 | 2.21 | 2.19 |
2.24
|
2.18
|
535K | 0.45% | |||
| Jul 31, 2023 | 2.2 | 2.18 |
2.21
|
2.17
|
1.4M | 0.92% | |||
| Jul 28, 2023 | 2.18 | 2.19 |
2.2
|
2.18
|
252K | -0.46% | |||
| Jul 27, 2023 | 2.19 | 2.18 |
2.2
|
2.18
|
519K | 0.46% | |||
| Jul 26, 2023 | 2.18 | 2.18 |
2.19
|
2.17
|
202K | 0% | |||
| Jul 25, 2023 | 2.18 | 2.18 |
2.19
|
2.18
|
110K | 0% | |||
| Jul 24, 2023 | 2.18 | 2.18 |
2.19
|
2.18
|
77.4K | -0.46% | |||
| Jul 21, 2023 | 2.19 | 2.19 |
2.19
|
2.18
|
565K | 0% | |||
| Jul 20, 2023 | 2.19 | 2.19 |
2.2
|
2.18
|
508K | 0% | |||
| Jul 19, 2023 | 2.19 | 2.19 |
2.2
|
2.18
|
219K | 0% | |||
| Jul 18, 2023 | 2.19 | 2.19 |
2.2
|
2.18
|
374K | 0% | |||
| Jul 17, 2023 | 2.19 | 2.2 |
2.2
|
2.18
|
662K | -0.45% | |||
| Jul 14, 2023 | 2.2 | 2.2 |
2.21
|
2.19
|
205K | 0% | |||
| Jul 13, 2023 | 2.2 | 2.19 |
2.21
|
2.19
|
218K | 0% | |||
| Jul 12, 2023 | 2.2 | 2.2 |
2.21
|
2.18
|
386K | 0.46% | |||
| Jul 11, 2023 | 2.19 | 2.19 |
2.19
|
2.18
|
229K | 0.46% | |||
| Jul 10, 2023 | 2.18 | 2.2 |
2.21
|
2.18
|
269K | -0.46% | |||
| Jul 7, 2023 | 2.19 | 2.2 |
2.21
|
2.18
|
511K | 0% | |||
| Jul 6, 2023 | 2.19 | 2.21 |
2.22
|
2.18
|
2.2M | -1.35% | |||
| Jul 5, 2023 | 2.22 | 2.2 |
2.23
|
2.19
|
324K | 0.45% | |||
| Jul 3, 2023 | 2.21 | 2.19 |
2.22
|
2.19
|
460K | 0% | |||
| Jun 30, 2023 | 2.21 | 2.19 |
2.22
|
2.18
|
675K | 0.91% | |||
| Jun 29, 2023 | 2.19 | 2.2 |
2.22
|
2.17
|
773K | -0.9% | |||
| Jun 28, 2023 | 2.21 | 2.21 |
2.22
|
2.2
|
526K | -0.9% | |||
| Jun 27, 2023 | 2.23 | 2.18 |
2.23
|
2.18
|
1.3M | 0% | |||